Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions) decreases the risk of skin cancer and early skin aging caused by the sun
puristics totallyageless spf 15 daily anti-aging
- Manufacturer
- Scerene Healthcare, Inc. | BioZone Laboratories, Inc.
- Effective date
- 2011-12-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:30:30
Label at a glance#
Productpuristics totallyageless spf 15 daily anti-aging
Active ingredientOctisalate, Zinc Oxide
Label structure9 sections
Dosage and administration
gently smooth over cleansed face and neck daily apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating children under 6 months of age: ask a doctor Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of...
Storage and handling
protect from excessive heat and direct sun
Contacts and useful links#
Websitewww.puristics.com
www.puristics.com
www.puristics.comLabel contents#
Full prescribing information#
Active ingredients
Octisalate 5%
Zinc oxide 3.75%
Purpose
Sunscreen
Uses
helps prevent sunburn
- if used as directed with other sun protection measures (see Directions) decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
Do not use on damaged or broken skin
When using the product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs
Keep out of reach of children.
If swallowed, get medical help or contact a PoisonControlCenter right away.
Directions
- gently smooth over cleansed face and neck daily
- apply liberally 15 minutes before sun exposure
- reapply at least every 2 hours
- use a water resistant sunscreen if swimming or sweating
- children under 6 months of age: ask a doctor
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m.-2 p.m.
- wear long-sleeved shirts, pants, hats, and sunglasses
Other information
- protect from excessive heat and direct sun
Inactive ingredients
purified water, caprylic/capric triglyceride (coconut/palm), squalane (olives), glycerin, tapioca starch, sucrose distearate (sugar), sucrose stearate, sunflower seed wax, palm butter, hydrogenated soybean oil, citric acid, lauric acid (coconut), beeswax, rice bran wax, allantoin, rosewood oil, tocopheryl acetate (vitamin E), panthenol (pro-vitamin B5), hyaluronic acid (natural skin conditioner), saccharomyces/hexapeptide-11 ferment extract (natural collagen builder), polylysine (natural preservative), honeysuckle extract (natural preservative)
Principal panel display
new!
the power of pure®
puristics®
totallyageless®
SPF 15
Daily Anti-Aging
SUNSCREEN LOTION
Broad Spectrum SPF 15
hydrates for younger looking skin
1.7 FL OZ (50 ml)
Pure. Safe. Effective.
naturally preserved & fragrance free
no parabens, phthalates or sulfates
no animal testing
Learn more at www.puristics.com
Puristics Totally Ageless SPF 15 Daily Anti-Aging Sunscreen Lotion is unique because it starts with purity and ends with purity. There are no harmful chemicals, fragrances or toxins added at any step in the process. Powered by a naturally occurring peptide complex, our vitamin enriched product has been proven to be safe and effective.
hydrates for younger looking skin
hypoallergenic
free from harmful chemicals
©2011 Distributed by
Scerene Healthcare, Inc.
Peapack, NJ 07977
1-877-267-0519
13010511
Actual Size
discover the power of pure
At Puristics, we believe in the Power of Pure - anti-aging skin care products without any potentially harmful chemicals that could seep into your skin. We’ve created our products using the latest science to unleash the power of naturally derived ingredients, combining them in unique ways to maximize their effectiveness without compromising purity.
Pure. Safe. Effective.
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76026-304-17 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-07e9-f424-e053-dadaa90a57ce | puristic ® totallyageless ® SPF 15 Daily Anti-Aging Sunscreen Lotion Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76026-304-17 | puristics totallyageless spf 15 daily anti-aging | 1 in 1 BOX | LOTION | 1 | 1 | |
| 76026-304-17 | puristics totallyageless spf 15 daily anti-aging | 50 mL in 1 BOTTLE, PUMP | LOTION | 50 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| Octisalate | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| .alpha.-tocopherol Acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| Allantoin | INACTIVE INGREDIENT | 344S277G0Z | 1 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| Elaeis Guineensis Fruit Butter | INACTIVE INGREDIENT | UYH3R74N56 | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Helianthus Annuus Seed Wax | INACTIVE INGREDIENT | 42DG15CHXV | 1 | |
| Hyaluronic Acid | INACTIVE INGREDIENT | S270N0TRQY | 1 | |
| Hydrogenated Soybean Oil | INACTIVE INGREDIENT | A2M91M918C | 1 | |
| Lauric Acid | INACTIVE INGREDIENT | 1160N9NU9U | 1 | |
| Lonicera Caprifolium Flower | INACTIVE INGREDIENT | 5N1WD9784U | 1 | |
| Lonicera Japonica Flower | INACTIVE INGREDIENT | 4465L2WS4Y | 1 | |
| Medium-chain Triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| Panthenol | INACTIVE INGREDIENT | WV9CM0O67Z | 1 | |
| Rice Bran | INACTIVE INGREDIENT | R60QEP13IC | 1 | |
| Rosewood Oil | INACTIVE INGREDIENT | F2522O5L7B | 1 | |
| Squalane | INACTIVE INGREDIENT | GW89575KF9 | 1 | |
| Starch, Tapioca | INACTIVE INGREDIENT | 24SC3U704I | 1 | |
| Sucrose Distearate | INACTIVE INGREDIENT | 96QS1D0T15 | 1 | |
| Sucrose Stearate | INACTIVE INGREDIENT | 274KW0O50M | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| Yellow Wax | INACTIVE INGREDIENT | 2ZA36H0S2V | 1 |
Products#
Every source-derived product name is available through these pages.
- puristics totallyageless spf 15 daily anti-aging
- octisalate, zinc oxide
- Octisalate
- Zinc Oxide
- Water
- Medium-chain Triglycerides
- Squalane
- Glycerin
- Starch, Tapioca
- Sucrose Distearate
- Sucrose Stearate
- Helianthus Annuus Seed Wax
- Elaeis Guineensis Fruit Butter
- Hydrogenated Soybean Oil
- Citric Acid Monohydrate
- Lauric Acid
- Yellow Wax
- Rice Bran
- Allantoin
- Rosewood Oil
- .alpha.-tocopherol Acetate
- Panthenol
- Hyaluronic Acid
- Lonicera Caprifolium Flower
- Lonicera Japonica Flower
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 76026-304 | 76026-304-17 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| Medium-chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CAPSULE / ORAL | 4771 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| Medium-chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER / SUBLINGUAL | 2 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | TABLET, EXTENDED RELEASE / ORAL | 0.01 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| Medium-chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 990.3 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 385 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| Medium-chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EFFERVESCENT / ORAL | 460 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAMUSCULAR | 28 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / TOPICAL | 0.01 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| Squalane | SQUALANE | GW89575KF9 | CREAM, AUGMENTED / TOPICAL | 120 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / SUBLINGUAL | 24 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, COATED / ORAL | NA | ||
| Medium-chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SUSPENSION / ORAL | 10170 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| Medium-chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CREAM / TOPICAL | 3300 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / PERIDURAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO / TOPICAL | 17 mg | ||
| Medium-chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | GEL / TOPICAL | 12 mg | ||
| Sucrose Stearate | SUCROSE STEARATE | 274KW0O50M | CREAM / TOPICAL | 5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / IONTOPHORESIS | 0.02 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| Squalane | SQUALANE | GW89575KF9 | AEROSOL, FOAM / TOPICAL | 2.23 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOAP / TOPICAL | 0.5 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / INTRAVENOUS | 0.2 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY, METERED / NASAL | 2 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Hydrogenated Soybean Oil | HYDROGENATED SOYBEAN OIL | A2M91M918C | CAPSULE / ORAL | 95 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| Medium-chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SOLUTION / ORAL | 5566 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5f4eb2f6-04e3-8103-88ea-bb3b615c8174 | 9734ecbe-b86d-573b-c805-00ee67e6111a | 2011-12-01 | Warnings | 5f4eb2f6-04e3-8103-88ea-bb3b615c8174 9734ecbe-b86d-573b-c805-00ee67e6111a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.